NYSE:SOLVMedical Equipment
Solventum (SOLV): Assessing Valuation After Balance Sheet Overhaul and 2025 Guidance Update
If you are watching Solventum (SOLV) after its recent moves, there is plenty to unpack. The company has just completed the sale of its Purification & Filtration business to Thermo Fisher Scientific and immediately put the $3.4 billion in proceeds to work by announcing a series of tender offers for its outstanding notes. These transactions are part of a larger plan to reshape its balance sheet and free up cash for potential new opportunities, which shows management’s focus on the long...